Exoskeleton by Wandercraft Walks Into a New Approval

Wandercraft, developer of the world’s first self-balancing robotic exoskeleton, scored a second U.S. win with a 510(k) approval of a trimmed-down version of Atalante X, intended for therapeutic rehab in patients with spinal cord injuries at levels T5-L5.

This range of spinal cord damage leaves upper body strength and mobility intact but can limit — or even destroy — lower limb sensation and movement. The device has a powered ankle mechanism that allows complex movements, mimicking natural human gait. While Wandercraft envisions the device as someday replacing a patient’s wheelchair for everyday activities, the new clearance focuses on therapist-lead rehab sessions.

The device, tested in 500 patients, is already approved in the U.S. for rehabilitation in stroke patients.

To read the whole story, click here to subscribe.

Related Topics